Preliminary data published in June 2023 also suggests that GLP-1 drugs 'could modulate crucial pathways in the pathogenesis of inflammatory bowel disease (IBD), such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity' (Arvanitakis, Theocharis, Popovic
Stereoisomerism: L-carnitine vs
Doctor Martin may also suggest a full blood panel to check for hormonal imbalances influencing your weight
Some patients experience more, and some experience less
A recent nationwide study in Denmark has revealed that women who start using semaglutide, a popular medication prescribed for weight loss, may experience a decrease in the need for standard migraine treatments
Short half-life peptides (hours) require daily or twice-daily dosing